NTC is a technology-based service company, providing vector development and manufacturing assistance to biotech companies and academic researchers worldwide.

5/28/02 Valentis Announces the Issuance of Two Broad Patents 5/20/02 Valentis Licenses Geneswitch Gene Regulation Technology to Medigene A.G. 2001 Valentis, Inc. ...

The new Journal of Gene Medicine from John Wiley & Sons ...

Gene therapy and cancer research tools: multigenic vectors, plasmid vectors, cytokines genes, chemokines genes, interleukines genes, interferons genes, apoptosis genes, angiostatic genes, tumor suppressors, selection agents, prodrugs, mycoplasma curing ...

Oxagen is a genomics company specialising in understanding the genetic basis of common human diseases.

Oxford BioMedica is a leader in gene transfer, gene regulation and modulation for developing therapeutics and in the field of functional genomics through target validation and discovery.

Gene Therapy Center University of North Carolina Administrative Information Human Applications Lab Principal Investigators MTA Order Form Vector Core Lab Samulski Lab WebmistressLinda L. Strother Updated 2/01 ...

A joint initiative of The Children's Hospital at Westmead and the Children's Medical Research Institute. This strategic partnership has allowed the development of a robust and successful scientific research and development program that is rapidly progressing from the laboratory bench to the patient bedside.

European Society of Gene Therapy ...

University of Michigan Medical System Center for Gene Therapy Search the CGT Website June 18, 2002 Announcement of next round of Pilot Grant Funding. Click here for details. Applications due Sept. 1, 2002. Feb. 25, 2002 Addition of Data & Safety Monitoring Committee to Clinical Trials Program Resources Seminar Series Membership Application Intramural Grant Program Clinical Protocols ...

The mission of the The Pittsburgh Human Gene Therapy Center is to foster the growth and development of multidisciplinary preclinical and clinical research programs aimed at the use of gene transfer technologies for the treatment of human disease.

BioVex is a functional genomics and gene therapy company. The company has created a proprietary gene delivery technology which has particular utility in the development of new drugs for cancer treatment and immune and nervous system ...

Molecular Medicine, based in San Diego, is a development and manufacturing company dedicated to the production of high-quality, clinical grade, gene and cell based therapeutics and reagents.

Gene Therapy Initiative, Harvard Institute of Human Genetics, Harvard Medical School, Children's Hospital, Boston. Conducts research developing novel gene delivery vector technologies. Research, Vector repository, Ordering info..

GenStar Therapeutics is a biopharmaceutical company developing innovative gene therapy products, for the treatment of serious medical disorders. The Company's research and development efforts, utilizing advanced gene delivery technologies, are focused on hemophilia, cancer, and HIV/AIDS. ...

Welcome to the Alberta Gene Therapy Group Home Page The Alberta Gene Therapy Group was born during a meeting organised by Lung-Ji Chang from the University of Alberta and Norman Wong from the University of Calgary held at the Holiday Inn, Red Deer, Alberta, November 23, Thursday, 1995. The Group is made up of people from the Unversity of Alberta, the Unversity of Calgary, the Alberta Cancer ...

Virapur sells virus purification kits for gene therapy and virus research. Fast and easy. No cesium gradients. Easy for the non-virologist.

VirRx is a biotechnology company with a primary interest in cancer gene therapy.

Cystic Fibrosis Gene Therapy, The Gene Medicine Research Group. Development of non viral gene therapy for cystic fibrosis. Nuffield Department of Clinical Biochemistry, John Radcliffe Hospital, Oxford University ...

INHERINET (Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases), an initiative founded by seven European research institutions, accumulates the expertise of biomedical scientists who have a strong background in the development of all platform technologies required for successful gene therapy: State-of -the-art design and production of retroviral and lentiviral gene transfer vectors ...